4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-18-049118
President and CEO sold 18,334 shares at $18.05 ($330,929)
From the SEC's structured data for this filing
Trades in this filing
Watts Ryan J. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-08-29 | Sale : show line 1 in the form | −18,334 | $18.05 | $330,929 | 2,784,304 | I |
| Open-market sales · 18,334 sh · avg $18.05 · $330,929 | ||||||
Loading xslF345X03/doc4.xml…